Filing metadata

Accession number
0001415889-24-014334
Form type
Form 4
Filer
Landos Biopharma, Inc.
CIK
CIK 1785345
Filed
May 23, 2024
Reporting period
May 23, 2024
Description
Insider transaction

Explore SEC Filings Hub